Articles

Kuiper, M.; van de Nes, A.; Nieuwland, R.; Varga, Z.; van der Pol, E. Reliable measurements of extracellular vesicles by clinical flow cytometry. Am. J. Reprod. Immunol. 2021, 85 (2), e13350.

Kuiper M, van de Nes A, Nieuwland R, Varga Z, van der Pol E. Reliable measurements of extracellular vesicles by clinical flow cytometry. . 2021;85(2):e13350.

M. Kuiper, A. van de Nes, R. Nieuwland, Z. Varga, and E. van der Pol, “Reliable measurements of extracellular vesicles by clinical flow cytometry,” Am. J. Reprod. Immunol., vol. 85, no. 2, pp. e13350, Feb. 2021.

Kuiper M, van de Nes A, Nieuwland R, Varga Z, van der Pol E. Reliable measurements of extracellular vesicles by clinical flow cytometry. . 2021 Feb;85(2):e13350.

Uil, M.; Hau, C. M.; Ahdi, M.; Mills, J. D.; Kers, J.; Saleem, M. A.; Florquin, S.; Gerdes, V. E. A.; Nieuwland, R.; Roelofs, J. J. T. H. Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy. Clinical Kidney Journal 2021, 14 (1), 358-365.

Uil M, Hau CM, Ahdi M, et al. Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy. . 2021;14(1):358-365.

M. Uil et al., “Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy,” Clinical Kidney Journal, vol. 14, no. 1, pp. 358-365, Jan. 2021.

Uil M, Hau CM, Ahdi M, Mills JD, Kers J, Saleem MA, et al. Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy. . 2021 Jan;14(1):358-365.

Gąsecka, A.; Pluta, K.; Solarska, K.; Rydz, B.; Eyileten, C.; Postuła, M.; van der Pol, E.; Nieuwland, R.; Budnik, M.; Kochanowski, J.; et al. Plasma concentrations of extracellular vesicles are decreased in patients with post-infarct cardiac remodelling. and Management of North Pacific Rockfishes 2021, 10 (2), 97.

Gąsecka A, Pluta K, Solarska K, et al. Plasma concentrations of extracellular vesicles are decreased in patients with post-infarct cardiac remodelling. . 2021;10(2):97.

A. Gąsecka et al., “Plasma concentrations of extracellular vesicles are decreased in patients with post-infarct cardiac remodelling,” and Management of North Pacific Rockfishes, vol. 10, no. 2, pp. 97, Jan. 2021.

Gąsecka A, Pluta K, Solarska K, Rydz B, Eyileten C, Postuła M, et al. Plasma concentrations of extracellular vesicles are decreased in patients with post-infarct cardiac remodelling. . 2021 Jan;10(2):97.

Nieuwland, R.; Falcón-Pérez, J. M.; Théry, C.; Witwer, K. W. Rigor and standardization of extracellular vesicle research: Paving the road towards robustness. J. Extracell. Vesicles 2020, 10 (2), e12037.

Nieuwland R, Falcón-Pérez JM, Théry C, Witwer KW. Rigor and standardization of extracellular vesicle research: Paving the road towards robustness. . 2020;10(2):e12037.

R. Nieuwland, J. M. Falcón-Pérez, C. Théry, and K. W. Witwer, “Rigor and standardization of extracellular vesicle research: Paving the road towards robustness,” J. Extracell. Vesicles, vol. 10, no. 2, pp. e12037, Dec. 2020.

Nieuwland R, Falcón-Pérez JM, Théry C, Witwer KW. Rigor and standardization of extracellular vesicle research: Paving the road towards robustness. . 2020 Dec;10(2):e12037.

Hu, Y.; Hell, L.; Kendlbacher, R. A.; Hajji, N.; Hau, C.; van Dam, A.; Berckmans, R. J.; Wisgrill, L.; Ay, C.; Pabinger, I.; et al. Human milk triggers coagulation via tissue factor-exposing extracellular vesicles. Blood advances 2020, 4 (24), 6274-6282.

Hu Y, Hell L, Kendlbacher RA, et al. Human milk triggers coagulation via tissue factor-exposing extracellular vesicles. . 2020;4(24):6274-6282.

Y. Hu et al., “Human milk triggers coagulation via tissue factor-exposing extracellular vesicles,” Blood advances, vol. 4, no. 24, pp. 6274-6282, Dec. 2020.

Hu Y, Hell L, Kendlbacher RA, Hajji N, Hau C, van Dam A, et al. Human milk triggers coagulation via tissue factor-exposing extracellular vesicles. . 2020 Dec;4(24):6274-82.

Welsh, J. A.; van der Pol, E.; Bettin, B. A.; Carter, D. R.; Hendrix, A.; Lenassi, M.; Langlois, M.; Llorente, A.; van de Nes, A. S.; Nieuwland, R.; et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size, and concentration. J. Extracell. Vesicles 2020, 9, 1816641.

Welsh JA, van der Pol E, Bettin BA, et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size, and concentration. . 2020;9:1816641.

J. A. Welsh et al., “Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size, and concentration,” J. Extracell. Vesicles, vol. 9, pp. 1816641, Sep. 2020.

Welsh JA, van der Pol E, Bettin BA, Carter DR, Hendrix A, Lenassi M, et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size, and concentration. . 2020 Sep;9:1816641.

Börger, V.; Weiss, D. J.; Anderson, J. D.; Borràs, F. E.; Bussolati, B.; Carter, D. R. F.; Dominici, M.; Falcón-Pérez, J. M.; Gimona, M.; Hill, A. F.; et al. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy 2020, 22 (9), 482-485.

Börger V, Weiss DJ, Anderson JD, et al. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. . 2020;22(9):482-485.

V. Börger et al., “International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19,” Cytotherapy, vol. 22, no. 9, pp. 482-485, Sep. 2020.

Börger V, Weiss DJ, Anderson JD, Borràs FE, Bussolati B, Carter DRF, et al. International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. . 2020 Sep;22(9):482-485.

Royo, F.; Théry, C.; Falcón-Pérez, J. M.; Nieuwland, R.; Witwer, K. W. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. Cells 2020, 9 (9), 1955.

Royo F, Théry C, Falcón-Pérez JM, Nieuwland R, Witwer KW. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. . 2020;9(9):1955.

F. Royo, C. Théry, J. M. Falcón-Pérez, R. Nieuwland, and K. W. Witwer, “Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee,” Cells, vol. 9, no. 9, pp. 1955, Aug. 2020.

Royo F, Théry C, Falcón-Pérez JM, Nieuwland R, Witwer KW. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. . 2020 Aug;9(9):1955.

Palviainen, M.; Saraswat, M.; Varga, Z.; Kitka, D.; Neuvonen, M.; Puhka, M.; Joenväärä, S.; Renkonen, R.; Nieuwland, R.; Takatalo, M.; et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery. PloS One 2020, 15 (8), e0236439.

Palviainen M, Saraswat M, Varga Z, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery. . 2020;15(8):e0236439.

M. Palviainen et al., “Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery,” PloS One, vol. 15, no. 8, pp. e0236439, Aug. 2020.

Palviainen M, Saraswat M, Varga Z, Kitka D, Neuvonen M, Puhka M, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo—Implications for biomarker discovery. . 2020 Aug;15(8):e0236439.

Jansen, M. P. B.; Pulskens, W. P. C.; Uil, M.; Claessen, N.; Nieuwenhuizen, G.; Standaar, D.; Hau, C. M.; Nieuwland, R.; Florquin, S.; Bemelman, F. J.; et al. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation. Nephrol. Dial. Transpl. 2020, 35 (8), 1320-1327.

Jansen MPB, Pulskens WPC, Uil M, et al. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation. . 2020;35(8):1320-1327.

M. P. B. Jansen et al., “Urinary mitochondrial DNA associates with delayed graft function following renal transplantation,” Nephrol. Dial. Transpl., vol. 35, no. 8, pp. 1320-1327, Aug. 2020.

Jansen MPB, Pulskens WPC, Uil M, Claessen N, Nieuwenhuizen G, Standaar D, et al. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation. . 2020 Aug;35(8):1320-1327.

Gasecka, A.; Rogula, S.; Eyileten, C.; Postuła, M.; Jaguszewski, M. J.; Kochman, J.; Mazurek, T.; Nieuwland, R.; Filipiak, K. J. Role of P2Y receptors in platelet extracellular vesicle release. Int. J. Mol. Sci. 2020, 21 (17), 6065.

Gasecka A, Rogula S, Eyileten C, et al. Role of P2Y receptors in platelet extracellular vesicle release. . 2020;21(17):6065.

A. Gasecka et al., “Role of P2Y receptors in platelet extracellular vesicle release,” Int. J. Mol. Sci., vol. 21, no. 17, pp. 6065, Aug. 2020.

Gasecka A, Rogula S, Eyileten C, Postuła M, Jaguszewski MJ, Kochman J, et al. Role of P2Y receptors in platelet extracellular vesicle release. . 2020 Aug;21(17):6065.

Rikkert, L. G.; Engelaer, M.; Hau, C. M.; Terstappen, L. W. M. M.; Nieuwland, R.; Coumans, F. A. W. Rate zonal centrifugation can partially separate platelets from platelet-derived vesicles. Research and practice in thrombosis and haemostasis 2020, 4 (6), e12366.

Rikkert LG, Engelaer M, Hau CM, Terstappen LWMM, Nieuwland R, Coumans FAW. Rate zonal centrifugation can partially separate platelets from platelet-derived vesicles. . 2020;4(6):e12366.

L. G. Rikkert, M. Engelaer, C. M. Hau, L. W. M. M. Terstappen, R. Nieuwland, and F. A. W. Coumans, “Rate zonal centrifugation can partially separate platelets from platelet-derived vesicles,” Research and practice in thrombosis and haemostasis, vol. 4, no. 6, pp. e12366, Jul. 2020.

Rikkert LG, Engelaer M, Hau CM, Terstappen LWMM, Nieuwland R, Coumans FAW. Rate zonal centrifugation can partially separate platelets from platelet-derived vesicles. . 2020 Jul;4(6):e12366.

Bexkens, M. L.; van Gestel, R. A.; van Breukelen, B.; Urbanus, R. T.; Brouwers, J. F.; Nieuwland, R.; Tielens, A. G. M.; van Hellemond, J. J. Schistosoma mansoni infection affects the proteome and lipidome of circulating extracellular vesicles in the host. Mol. Biochem. Parasit. 2020, 238, 111296.

Bexkens ML, van Gestel RA, van Breukelen B, et al. Schistosoma mansoni infection affects the proteome and lipidome of circulating extracellular vesicles in the host. . 2020;238:111296.

M. L. Bexkens et al., “Schistosoma mansoni infection affects the proteome and lipidome of circulating extracellular vesicles in the host,” Mol. Biochem. Parasit., vol. 238, pp. 111296, Jul. 2020.

Bexkens ML, van Gestel RA, van Breukelen B, Urbanus RT, Brouwers JF, Nieuwland R, et al. Schistosoma mansoni infection affects the proteome and lipidome of circulating extracellular vesicles in the host. . 2020 Jul;238:111296.

de Rond, L.; van der Pol, E.; Bloemen, P. R.; van den Broeck, T.; Monheim, L.; Nieuwland, R.; van Leeuwen, T. G.; Coumans, F. A. A systematic approach to improve scatter sensitivity of a flow cytometer for detection of extracellular vesicles. Cytom. Part A 2020, 97 (6), 582-591.

de Rond L, van der Pol E, Bloemen PR, et al. A systematic approach to improve scatter sensitivity of a flow cytometer for detection of extracellular vesicles. . 2020;97(6):582-591.

L. de Rond et al., “A systematic approach to improve scatter sensitivity of a flow cytometer for detection of extracellular vesicles,” Cytom. Part A, vol. 97, no. 6, pp. 582-591, Jun. 2020.

de Rond L, van der Pol E, Bloemen PR, van den Broeck T, Monheim L, Nieuwland R, et al. A systematic approach to improve scatter sensitivity of a flow cytometer for detection of extracellular vesicles. . 2020 Jun;97(6):582-91.

Rikkert, L. G.; De Rond, L.; van Dam, A.; van Leeuwen, T. G.; Coumans, F. A. W.; de Reijke, T. M.; Terstappen, L. W. M. M.; Nieuwland, R. Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging. PLoS One 2020, 15 (6), e0233443.

Rikkert LG, De Rond L, van Dam A, et al. Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging. . 2020;15(6):e0233443.

L. G. Rikkert et al., “Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging,” PLoS One, vol. 15, no. 6, pp. e0233443, Jun. 2020.

Rikkert LG, De Rond L, van Dam A, van Leeuwen TG, Coumans FAW, de Reijke TM, et al. Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging. . 2020 Jun;15(6):e0233443.

Kastelein, A. W.; Vos, L. M. C.; van Baal, J. O. A. M.; Koning, J. J.; Hira, V. V. V.; Nieuwland, R.; van Driel, W. J.; Uz, Z.; van Gulik, T. M.; van Rheenen, J.; et al. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer. Clinical & Experimental Metastasis 2020, 37 (2), 293-304.

Kastelein AW, Vos LMC, van Baal JOAM, et al. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer. . 2020;37(2):293-304.

A. W. Kastelein et al., “Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer,” Clinical & Experimental Metastasis, vol. 37, no. 2, pp. 293-304, Apr. 2020.

Kastelein AW, Vos LMC, van Baal JOAM, Koning JJ, Hira VVV, Nieuwland R, et al. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer. . 2020 Apr;37(2):293-304.

Rikkert, L. G.; Beekman, P.; Caro, J.; Coumans, F. A. W.; Enciso Martinez, A.; Jenster, G.; Le Gac, S.; Lee, W.; van Leeuwen, T. G.; Loozen, G. B.; et al. Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood. Front. Oncol. 2020, 10, 608.

Rikkert LG, Beekman P, Caro J, et al. Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood. . 2020;10:608.

L. G. Rikkert et al., “Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood,” Front. Oncol., vol. 10, pp. 608, Jun. 2020.

Rikkert LG, Beekman P, Caro J, Coumans FAW, Enciso Martinez A, Jenster G, et al. Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood. . 2020 Jun;10:608.

Welsh, J. A.; van der Pol, E.; Arkesteijn, G. J. A.; Bremer, M.; Brisson, A.; Coumans, F.; Dignat-George, F.; Duggan, E.; Ghiran, I.; Giebel, B.; et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J. Extracell. Vesicles 2020, 9, 1713526.

Welsh JA, van der Pol E, Arkesteijn GJA, et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. . 2020;9:1713526.

J. A. Welsh et al., “MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments,” J. Extracell. Vesicles, vol. 9, pp. 1713526, Feb. 2020.

Welsh JA, van der Pol E, Arkesteijn GJA, Bremer M, Brisson A, Coumans F, et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. . 2020 Feb;9:1713526.

Enciso-Martinez, A.; van der Pol, E.; Lenferink, A. T. M.; Terstappen, L. W. M. M.; van Leeuwen, T. G.; Otto, C. Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles. Nanomedicine: Nanotechnology, Biology and Medicine 2020, 24, 102109.

Enciso-Martinez A, van der Pol E, Lenferink ATM, Terstappen LWMM, van Leeuwen TG, Otto C. Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles. . 2020;24:102109.

A. Enciso-Martinez, E. van der Pol, A. T. M. Lenferink, L. W. M. M. Terstappen, T. G. van Leeuwen, and C. Otto, “Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 24, pp. 102109, Feb. 2020.

Enciso-Martinez A, van der Pol E, Lenferink ATM, Terstappen LWMM, van Leeuwen TG, Otto C. Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles. . 2020 Feb;24:102109.

Enciso-Martinez, A.; van der Pol, E.; Hau, C. M.; Nieuwland, R.; van Leeuwen, T. G.; Terstappen, L. W. M. M.; Otto, C. Label-free identification and chemical characterisation of single extracellular vesicles and lipoproteins by synchronous Rayleigh and Raman scattering. J. Extracell. Vesicles 2020, 9, 1730134.

Enciso-Martinez A, van der Pol E, Hau CM, et al. Label-free identification and chemical characterisation of single extracellular vesicles and lipoproteins by synchronous Rayleigh and Raman scattering. . 2020;9:1730134.

A. Enciso-Martinez et al., “Label-free identification and chemical characterisation of single extracellular vesicles and lipoproteins by synchronous Rayleigh and Raman scattering,” J. Extracell. Vesicles, vol. 9, pp. 1730134, Feb. 2020.

Enciso-Martinez A, van der Pol E, Hau CM, Nieuwland R, van Leeuwen TG, Terstappen LWMM, et al. Label-free identification and chemical characterisation of single extracellular vesicles and lipoproteins by synchronous Rayleigh and Raman scattering. . 2020 Feb;9:1730134.

Gasecka, A.; Nieuwland, R.; Budnik, M.; Dignat-George, F.; Eyileten, C.; Harrison, P.; Huczek, Z.; Kapłon-Cieślicka, A.; Lacroix, R.; Opolski, G.; et al. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. Platelets 2020, 31 (1), 26-32.

Gasecka A, Nieuwland R, Budnik M, et al. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. . 2020;31(1):26-32.

A. Gasecka et al., “Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction,” Platelets, vol. 31, no. 1, pp. 26-32, Jan. 2020.

Gasecka A, Nieuwland R, Budnik M, Dignat-George F, Eyileten C, Harrison P, et al. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. . 2020 Jan;31(1):26-2.

Gasecka, A.; Nieuwland, R.; Budnik, M.; Dignat-George, F.; Eyileten, C.; Harrison, P.; Lacroix, R.; Leroyer, A.; Opolski, G.; Pluta, K.; et al. Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. J. Thromb. Haemost. 2020, 18 (3), 609-623.

Gasecka A, Nieuwland R, Budnik M, et al. Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. . 2020;18(3):609-623.

A. Gasecka et al., “Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel,” J. Thromb. Haemost., vol. 18, no. 3, pp. 609-623, Jan. 2020.

Gasecka A, Nieuwland R, Budnik M, Dignat-George F, Eyileten C, Harrison P, et al. Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. . 2020 Jan;18(3):609-23.

van Hezel, M. E.; van Manen, L.; Boshuizen, M.; Straat, M.; De Cuyper, I. M.; Beuger, B.; Nieuwland, R.; Tanck, M. W. T.; de Korte, D.; Zwaginga, J. J.; et al. The effect of red blood cell transfusion on platelet function in critically ill patients. Thromb. Res. 2019, 184, 115-121.

van Hezel ME, van Manen L, Boshuizen M, et al. The effect of red blood cell transfusion on platelet function in critically ill patients. . 2019;184:115-121.

M. E. van Hezel et al., “The effect of red blood cell transfusion on platelet function in critically ill patients,” Thromb. Res., vol. 184, pp. 115-121, Dec. 2019.

van Hezel ME, van Manen L, Boshuizen M, Straat M, De Cuyper IM, Beuger B, et al. The effect of red blood cell transfusion on platelet function in critically ill patients. . 2019 Dec;184:115-121.

Florijn, B. W.; Duijs, J. M. G. J.; Levels, J. H.; Dallinga-Thie, G. M.; Wang, Y.; Boing, A. N.; Yuana, Y.; Stam, W.; Limpens, R. W. A. L.; Au, Y. W.; et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. Diabetes 2019, 68 (12), 2287-2300.

Florijn BW, Duijs JMGJ, Levels JH, et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. . 2019;68(12):2287-2300.

B. W. Florijn et al., “Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2,” Diabetes, vol. 68, no. 12, pp. 2287-2300, Dec. 2019.

Florijn BW, Duijs JMGJ, Levels JH, Dallinga-Thie GM, Wang Y, Boing AN, et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. . 2019 Dec;68(12):2287-2300.

Berckmans, R. J.; Lacroix, R.; Hau, C. M.; Sturk, A.; Nieuwland, R. Extracellular vesicles and coagulation in blood from healthy humans revisited. J. Extracell. Vesicles 2019, 8 (1), 1688936.

Berckmans RJ, Lacroix R, Hau CM, Sturk A, Nieuwland R. Extracellular vesicles and coagulation in blood from healthy humans revisited. . 2019;8(1):1688936.

R. J. Berckmans, R. Lacroix, C. M. Hau, A. Sturk, and R. Nieuwland, “Extracellular vesicles and coagulation in blood from healthy humans revisited,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1688936, Nov. 2019.

Berckmans RJ, Lacroix R, Hau CM, Sturk A, Nieuwland R. Extracellular vesicles and coagulation in blood from healthy humans revisited. . 2019 Nov;8(1):1688936.

van Manen, L.; Peters, A. L.; van der Sluijs, P. M.; Nieuwland, R.; van Bruggen, R.; Juffermans, N. P. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. Transfus. Apher. Sci. 2019, 58 (4), 508-511.

van Manen L, Peters AL, van der Sluijs PM, Nieuwland R, van Bruggen R, Juffermans NP. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. . 2019;58(4):508-511.

L. van Manen, A. L. Peters, P. M. van der Sluijs, R. Nieuwland, R. van Bruggen, and N. P. Juffermans, “Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model,” Transfus. Apher. Sci., vol. 58, no. 4, pp. 508-511, Aug. 2019.

van Manen L, Peters AL, van der Sluijs PM, Nieuwland R, van Bruggen R, Juffermans NP. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. . 2019 Aug;58(4):508-511.

Nieuwland, R.; Gardiner, C.; Dignat-George, F.; Mullier, F.; Mackman, N.; Woodhams, B.; Thaler, J. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J. Thromb. Haemost. 2019, 17 (8), 1261-1264.

Nieuwland R, Gardiner C, Dignat-George F, et al. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. . 2019;17(8):1261-1264.

R. Nieuwland et al., “Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity,” J. Thromb. Haemost., vol. 17, no. 8, pp. 1261-1264, Aug. 2019.

Nieuwland R, Gardiner C, Dignat-George F, Mullier F, Mackman N, Woodhams B, et al. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. . 2019 Aug;17(8):1261-1264.

Kastelein, A. W.; Vos, L. M. C.; de Jong, K. H.; van Baal, J. O. A. M.; Nieuwland, R.; van Noorden, C. J. F.; Roovers, J. W. R.; Lok, C. A. R. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Seminars in Cell & Developmental Biology 2019, 92 (2019), 27-36.

Kastelein AW, Vos LMC, de Jong KH, et al. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. . 2019;92(2019):27-36.

A. W. Kastelein et al., “Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature,” Seminars in Cell & Developmental Biology, vol. 92, no. 2019, pp. 27-36, Aug. 2019.

Kastelein AW, Vos LMC, de Jong KH, van Baal JOAM, Nieuwland R, van Noorden CJF, et al. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. . 2019 Aug;92(2019):27-36.

Horrevorts, S. K.; Stolk, D. A.; van de Ven, R.; Hulst, M.; van het Hof, B.; Duinkerken, S.; Heineke, M. H.; Ma, W.; Dusoswa, S. A.; Nieuwland, R.; et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. Cancers 2019, 11 (9), 1266.

Horrevorts SK, Stolk DA, van de Ven R, et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. . 2019;11(9):1266.

S. K. Horrevorts et al., “Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination,” Cancers, vol. 11, no. 9, pp. 1266, Aug. 2019.

Horrevorts SK, Stolk DA, van de Ven R, Hulst M, van het Hof B, Duinkerken S, et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. . 2019 Aug;11(9):1266.

Dusoswa, S. A.; Horrevorts, S. K.; Ambrosini, M.; Kalay, H.; Paauw, N. J.; Nieuwland, R.; Pegtel, M. D.; Würdinger, T.; Van Kooyk, Y.; Garcia-Vallejo, J. J. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. Journal of extracellular vesicles 2019, 8 (1), 1648995.

Dusoswa SA, Horrevorts SK, Ambrosini M, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. . 2019;8(1):1648995.

S. A. Dusoswa et al., “Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells,” Journal of extracellular vesicles, vol. 8, no. 1, pp. 1648995, Aug. 2019.

Dusoswa SA, Horrevorts SK, Ambrosini M, Kalay H, Paauw NJ, Nieuwland R, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. . 2019 Aug;8(1):1648995.

Clayton, A.; Boilard, E.; Buzas, E. I.; Cheng, L.; Falcón-Perez, J. M.; Gardiner, C.; Gustafson, D.; Gualerzi, A.; Hendrix, A.; Hoffman, A.; et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J. Extracell. Vesicles 2019, 8 (1), 1647027.

Clayton A, Boilard E, Buzas EI, et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. . 2019;8(1):1647027.

A. Clayton et al., “Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1647027, Aug. 2019.

Clayton A, Boilard E, Buzas EI, Cheng L, Falcón-Perez JM, Gardiner C, et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. . 2019 Aug;8(1):1647027.

Naik, J.; Hau, C. M.; ten Bloemendaal, L.; Mok, K. S.; Hajji, N.; Wehman, A. M.; Meisner, S.; Muncan, V.; Paauw, N. J.; de Vries, H. E.; et al. The P4-ATPase ATP9A is a novel determinant of exosome release. PLoS One 2019, 14 (4), e0213069.

Naik J, Hau CM, ten Bloemendaal L, et al. The P4-ATPase ATP9A is a novel determinant of exosome release. . 2019;14(4):e0213069.

J. Naik et al., “The P4-ATPase ATP9A is a novel determinant of exosome release,” PLoS One, vol. 14, no. 4, pp. e0213069, Apr. 2019.

Naik J, Hau CM, ten Bloemendaal L, Mok KS, Hajji N, Wehman AM, et al. The P4-ATPase ATP9A is a novel determinant of exosome release. . 2019 Apr;14(4):e0213069.

Ayers, L.; Pink, R.; Carter, D. R. F.; Nieuwland, R. Clinical requirements for extracellular vesicle assays. J. Extracell. Vesicles 2019, 8 (1), 1593755.

Ayers L, Pink R, Carter DRF, Nieuwland R. Clinical requirements for extracellular vesicle assays. . 2019;8(1):1593755.

L. Ayers, R. Pink, D. R. F. Carter, and R. Nieuwland, “Clinical requirements for extracellular vesicle assays,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1593755, Mar. 2019.

Ayers L, Pink R, Carter DRF, Nieuwland R. Clinical requirements for extracellular vesicle assays. . 2019 Mar;8(1):1593755.

Rikkert, L. G.; Nieuwland, R.; Terstappen, L. W. M. M.; Coumans, F. A. W. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J. Extracell. Vesicles 2019, 8 (1), 1555419.

Rikkert LG, Nieuwland R, Terstappen LWMM, Coumans FAW. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. . 2019;8(1):1555419.

L. G. Rikkert, R. Nieuwland, L. W. M. M. Terstappen, and F. A. W. Coumans, “Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1555419, Jan. 2019.

Rikkert LG, Nieuwland R, Terstappen LWMM, Coumans FAW. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. . 2019 Jan;8(1):1555419.

Gasecka, A.; Nieuwland, R.; van der Pol, E.; Hajji, N.; Ćwiek, A.; Pluta, K.; Konwerski, M.; Filipiak, K. J. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Cardiol. J. 2019, 26 (6), 782-789.

Gasecka A, Nieuwland R, van der Pol E, et al. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. . 2019;26(6):782-789.

A. Gasecka et al., “P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets,” Cardiol. J., vol. 26, no. 6, pp. 782-789, Nov. 2019.

Gasecka A, Nieuwland R, van der Pol E, Hajji N, Ćwiek A, Pluta K, et al. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. . 2019 Nov;26(6):782-9.

Cossarizza, A.; Chang, H.; Radbruch, A.; Acs, A.; Adam, D.; Adam-Klages, S.; Agace, W. W.; Aghaeepour, N.; Akdis, M.; Allez, M.; et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol. 2019, 49 (10), 1457-1973.

Cossarizza A, Chang H, Radbruch A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). . 2019;49(10):1457-1973.

A. Cossarizza et al., “Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition),” Eur. J. Immunol., vol. 49, no. 10, pp. 1457-1973, Oct.. 2019.

Cossarizza A, Chang H, Radbruch A, Acs A, Adam D, Adam-Klages S, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). . 2019 Oct.;49(10):1457-973.

de Rond, L.; Libregts, S. F. W. M.; Rikkert, L. G.; Hau, C. M.; van der Pol, E.; Nieuwland, R.; van Leeuwen, T. G.; Coumans, F. A. W. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. J. Extracell. Vesicles 2019, 8, 1643671.

de Rond L, Libregts SFWM, Rikkert LG, et al. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. . 2019;8:1643671.

L. de Rond et al., “Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry,” J. Extracell. Vesicles, vol. 8, pp. 1643671, Jul. 2019.

de Rond L, Libregts SFWM, Rikkert LG, Hau CM, van der Pol E, Nieuwland R, et al. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. . 2019 Jul;8:1643671.

Pieragostino, D.; Lanuti, P.; Cicalini, I.; Cufaro, M. C.; Ciccocioppo, F.; Ronci, M.; Simeone, P.; Onofrj, M.; van der Pol, E.; Fontana, A.; et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J. Proteomics 2019, 204, 103403.

Pieragostino D, Lanuti P, Cicalini I, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. . 2019;204:103403.

D. Pieragostino et al., “Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis,” J. Proteomics, vol. 204, pp. 103403, Jul. 2019.

Pieragostino D, Lanuti P, Cicalini I, Cufaro MC, Ciccocioppo F, Ronci M, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. . 2019 Jul;204:103403.

Tang, V. A.; Fritzsche, A. K.; Renner, T. M.; Burger, D.; van der Pol, E.; Lannigan, J. A.; Brittain, G. C.; Welsh, J. A.; Jones, J. C.; Langlois, M. Engineered retroviruses as fluorescent biological reference particles for nanoscale flow cytometry. BioRxiv, in press.

Tang VA, Fritzsche AK, Renner TM, et al. Engineered retroviruses as fluorescent biological reference particles for nanoscale flow cytometry. . In press.

V. A. Tang et al., “Engineered retroviruses as fluorescent biological reference particles for nanoscale flow cytometry,” BioRxiv, in press.

Tang VA, Fritzsche AK, Renner TM, Burger D, van der Pol E, Lannigan JA, et al. Engineered retroviruses as fluorescent biological reference particles for nanoscale flow cytometry. . In press.

Geeurickx, E.; Tulkens, J.; Dhondt, B.; Van Deun, J.; Lippens, L.; Vergauwen, G.; Heyrman, E.; De Sutter, D.; Gevaert, K.; Impens, F.; et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat. Commun. 2019, 10 (1), 1-12.

Geeurickx E, Tulkens J, Dhondt B, et al. The generation and use of recombinant extracellular vesicles as biological reference material. . 2019;10(1):1-12.

E. Geeurickx et al., “The generation and use of recombinant extracellular vesicles as biological reference material,” Nat. Commun., vol. 10, no. 1, pp. 1-12, Jun. 2019.

Geeurickx E, Tulkens J, Dhondt B, Van Deun J, Lippens L, Vergauwen G, et al. The generation and use of recombinant extracellular vesicles as biological reference material. . 2019 Jun;10(1):1-2.

Rank, A.; Nieuwland, R.; Köhler, A.; Franz, C.; Waidhauser, J.; Toth, B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. PLOS one 2018, 13 (12), 1-11.

Rank A, Nieuwland R, Köhler A, Franz C, Waidhauser J, Toth B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. . 2018;13(12):1-11.

A. Rank, R. Nieuwland, A. Köhler, C. Franz, J. Waidhauser, and B. Toth, “Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution,” PLOS one, vol. 13, no. 12, pp. 1-11, Dec. 2018.

Rank A, Nieuwland R, Köhler A, Franz C, Waidhauser J, Toth B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. . 2018 Dec;13(12):1-11.

Nieuwland, R.; Falcon-Perez, J. M.; Soekmadji, C.; Boilard, E.; Carter, D.; Buzas, E. I. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. J. Extracell. Vesicles 2018, 7 (1), 1548234.

Nieuwland R, Falcon-Perez JM, Soekmadji C, Boilard E, Carter D, Buzas EI. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. . 2018;7(1):1548234.

R. Nieuwland, J. M. Falcon-Perez, C. Soekmadji, E. Boilard, D. Carter, and E. I. Buzas, “Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1548234, Nov. 2018.

Nieuwland R, Falcon-Perez JM, Soekmadji C, Boilard E, Carter D, Buzas EI. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. . 2018 Nov;7(1):1548234.

Théry, C.; Witwer, K. W.; Aikawa, E.; Alcaraz, M. J.; Anderson, J. D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G. K.; et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018, 7 (1), 1535750.

Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. . 2018;7(1):1535750.

C. Théry et al., “Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1535750, Sep. 2018.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. . 2018 Sep;7(1):1535750.

Yu, Y.; Gool, E.; Berckmans, R. J.; Coumans, F. A. W.; Barendrecht, A. D.; Maas, C.; van der Wel, N. N.; Altevogt, P.; Sturk, A.; Nieuwland, R. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. J. Thromb. Haemost. 2018, 16 (6), 1153-1163.

Yu Y, Gool E, Berckmans RJ, et al. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. . 2018;16(6):1153-1163.

Y. Yu et al., “Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets,” J. Thromb. Haemost., vol. 16, no. 6, pp. 1153-1163, Jun. 2018.

Yu Y, Gool E, Berckmans RJ, Coumans FAW, Barendrecht AD, Maas C, et al. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. . 2018 Jun;16(6):1153-1163.

van Es, N.; Hisada, Y.; Di Nisio, M.; Cesarman, G.; Kleinjan, A.; Mahé, I.; Otten, H.; Kamphuisen, P. W.; Berckmans, R. J.; Büller, H. R.; et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb. Res. 2018, 166, 54-59.

van Es N, Hisada Y, Di Nisio M, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. . 2018;166:54-59.

N. van Es et al., “Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study,” Thromb. Res., vol. 166, pp. 54-59, Jun. 2018.

van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. . 2018 Jun;166:54-59.

Clayton, A.; Buschmann, D.; Byrd, J. B.; Carter, D. R. F.; Cheng, L.; Compton, C.; Daaboul, G.; Devitt, A.; Falcon-Perez, J. M.; Gardiner, C.; et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J. Extracell. Vesicles 2018, 7 (1), 1473707.

Clayton A, Buschmann D, Byrd JB, et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. . 2018;7(1):1473707.

A. Clayton et al., “Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1473707, May. 2018.

Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. . 2018 May;7(1):1473707.

van Baal, J. O. A. M.; van Noorden, C. J. F.; Nieuwland, R.; van de Vijver, K. K.; Sturk, A.; van Driel, W. J.; Kenter, G. G.; Lok, C. A. R. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. Journal of Histochemistry & Cytochemistry 2018, 66 (2), 67-83.

van Baal JOAM, van Noorden CJF, Nieuwland R, et al. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. . 2018;66(2):67-83.

J. O. A. M. van Baal et al., “Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review,” Journal of Histochemistry & Cytochemistry, vol. 66, no. 2, pp. 67-83, Feb. 2018.

van Baal JOAM, van Noorden CJF, Nieuwland R, van de Vijver KK, Sturk A, van Driel WJ, et al. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. . 2018 Feb;66(2):67-83.

Karimi, N.; Cvjetkovic, A.; Jang, S. C.; Crescitelli, R.; Ali Hosseinpour Feizi, M.; Nieuwland, R.; Lötvall, J.; Lässer, C. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. Cellular and Moleclular Life Sciences 2018, 75 (15), 2873-2886.

Karimi N, Cvjetkovic A, Jang SC, et al. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. . 2018;75(15):2873-2886.

N. Karimi et al., “Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins,” Cellular and Moleclular Life Sciences, vol. 75, no. 15, pp. 2873-2886, Feb. 2018.

Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Ali Hosseinpour Feizi M, Nieuwland R, et al. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. . 2018 Feb;75(15):2873-2886.

Rikkert, L. G.; van der Pol, E.; van Leeuwen, T. G.; Nieuwland, R.; Coumans, F. A. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. Cytom. Part A 2018, 93 (12), 1207-1212.

Rikkert LG, van der Pol E, van Leeuwen TG, Nieuwland R, Coumans FA. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. . 2018;93(12):1207-1212.

L. G. Rikkert, E. van der Pol, T. G. van Leeuwen, R. Nieuwland, and F. A. Coumans, “Centrifugation affects the purity of liquid biopsy-based tumor biomarkers,” Cytom. Part A, vol. 93, no. 12, pp. 1207-1212, Dec. 2018.

Rikkert LG, van der Pol E, van Leeuwen TG, Nieuwland R, Coumans FA. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. . 2018 Dec;93(12):1207-12.